National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 4634 [2022-01744]
Download as PDF
<![CDATA[
4634
Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIGMS Initial Review
Group Training and Workforce Development
Study Section—D Review of Bridges to the
Baccalaureate Applications.
Date: March 3, 2022.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Video Meeting).
Contact Person: Tracy Koretsky, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, MSC 6200, Room 3AN.12F,
Bethesda, MD 20892, (301) 594–2886,
tracy.koretsky@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.859, Biomedical Research and
Research Training, National Institutes of
Health, HHS)
Dated: January 24, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–01742 Filed 1–27–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
jspears on DSK121TN23PROD with NOTICES1
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
18:03 Jan 27, 2022
Jkt 256001
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Support for Research
Excellence—First Independent Research
(SuRE-First) Award (R16—Clinical Trial Not
Allowed).
Date: February 25, 2022.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F36,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Noton K. Dutta, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F36, Rockville, MD
20852, 240–669–2857, noton.dutta@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–01744 Filed 1–27–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[CBP Dec. 22–01]
Notice of Finding That Certain Seafood
Harvested by the Taiwanese Da Wang
Fishing Vessel With the Use of
Convict, Forced or Indentured Labor Is
Being, or Is Likely To Be, Imported Into
the United States in Violation of 19
U.S.C. i307
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice of forced labor
finding.
AGENCY:
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
VerDate Sep<11>2014
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
This document notifies the
public that U.S. Customs and Border
Protection (CBP), with the approval of
the Secretary of Homeland Security, has
determined that certain seafood has
SUMMARY:
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
been harvested by the Da Wang fishing
vessel with the use of convict, forced or
indentured labor, and is being, or is
likely to be, imported into the United
States.
DATES: This Finding applies to any
merchandise described in Section II of
this Notice that is imported on or after
January 28, 2022. It also applies to
merchandise which has already been
imported and has not been released
from CBP custody before January 28,
2022.
FOR FURTHER INFORMATION CONTACT:
Ilissa Shefferman, Chief, Investigations
Branch, Forced Labor Division, Trade
Remedy Law Enforcement Directorate,
Office of Trade, (202) 506–5663 or
forcedlabor@cbp.dhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Pursuant to section 307 of the Tariff
Act of 1930, as amended (19 U.S.C.
1307), ‘‘[a]ll goods, wares, articles, and
merchandise mined, produced or
manufactured wholly or in part in any
foreign country by convict labor or/and
forced labor or/and indentured labor
under penal sanctions shall not be
entitled to entry at any of the ports of
the United States, and the importation
thereof is hereby prohibited.’’ Under
this section, ‘‘forced labor’’ includes ‘‘all
work or service which is exacted from
any person under the menace of any
penalty for its nonperformance and for
which the worker does not offer himself
voluntarily’’ and includes forced or
indentured child labor.
The Customs and Border Protection
(CBP) regulations promulgated under
the authority of 19 U.S.C. 1307 are
found at sections 12.42 through 12.45 of
title 19, Code of Federal Regulations
(CFR) (19 CFR 12.42–12.45). Among
other things, these regulations allow any
person outside of CBP to communicate
his or her belief that a certain ‘‘class of
merchandise . . . is being, or is likely
to be, imported into the United States
[in violation of 19 U.S.C. 1307].’’ 19 CFR
12.42(a), (b). Upon receiving such
information, the Commissioner of CBP
will initiate an investigation if
warranted by the circumstances. 19 CFR
12.42(d). CBP also has the authority to
self-initiate an investigation. 19 CFR
12.42(a). If the Commissioner finds that
the information available ‘‘reasonably
but not conclusively’’ indicates that
such merchandise ‘‘is being, or is likely
to be, imported’’ into the United States,
the Commissioner will order port
directors to ‘‘withhold release of the
merchandise pending [further]
instructions.’’ 19 CFR 12.42(e). After
issuance of a withhold release order, the
E:\FR\FM\28JAN1.SGM
28JAN1
]]>Agencies
[Federal Register Volume 87, Number 19 (Friday, January 28, 2022)]
[Notices]
[Page 4634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-01744]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel Support for Research Excellence--
First Independent Research (SuRE-First) Award (R16--Clinical Trial
Not Allowed).
Date: February 25, 2022.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F36,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Noton K. Dutta, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F36,
Rockville, MD 20852, 240-669-2857, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: January 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-01744 Filed 1-27-22; 8:45 am]
BILLING CODE 4140-01-P
